CLOs on the Move

Endologix

www.endologix.com

 
Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company`s focus is endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S. Approximately 1.7 million Americans have AAA, and the incidence of the condition increases with age. Endologix is ...
  • Number of Employees: 250-1000
  • Annual Revenue: $250-500 Million

Executives

Name Title Contact Details
Elisa Hebb
Vice President, Clinical and Regulatory Affairs Profile
Christopher LaQuay
Associate General Counsel Profile

Similar Companies

HemoSense

HemoSense is a San Jose, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

American I.V.Products

American I.V.Products is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

Clinicon Corporation

Clinicon Corporation is a Oceanside, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Avita Medical

Avita Medical is a publicly listed regenerative medicine company trading on the Australian Stock Exchange (ASX:AVH) and OTC Markets (OTCQX:AVMXY). The company`s lead product, ReCell® is used in a wide variety of burns, chronic wounds, plastic, reconstructive and cosmetic procedures. ReCell is patented, CE-marked for Europe, TGA- registered in Australia, and SFDA-cleared in China. ReCell is not available for sale in the United States; in the US ReCell is an investigational device limited by federal law to investigational use.

Del Norte Clinics

Del Norte Clinics is a Yuba City, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.